Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients

BACKGROUND: We report the safety and efficacy of eribulin as a late treatment line in Thai metastatic breast cancer (MBC) patients. PATIENTS AND METHODS: A total of 30 MBC patients treated with eribulin between January 2014 and January 2017 were retrospectively analyzed. The patients were scheduled...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Onco Targets Ther
Egile Nagusiak: Ditsatham, Chagkrit, Chitapanarux, Imjai, Somwangprasert, Areewan, Watcharachan, Kirati, Wongmaneerung, Panchaporn, Charoentum, Chaiyut, Chewaskulyong, Busyamas, Chakrabandhu, Somvilai, Onchan, Wimrak, Teeyasuntranonn, Anongnart, Sripan, Patumrat
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6074808/
https://ncbi.nlm.nih.gov/pubmed/30104885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S166399
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak